Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Identify new genes responsible for autosomal dominant retinitis pigmentosa (ADRP), one of the most common causes of hereditary diseases of the retina, and thus better understand the mechanisms involved of the disease."
| Condition | Intervention |
|---|---|
|
Autosomal Dominant Retinitis Pigmentosa |
Genetic: genetic analysis |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes |
| Estimated Enrollment: | 250 |
| Study Start Date: | March 2009 |
| Estimated Study Completion Date: | March 2012 |
| Estimated Primary Completion Date: | March 2011 (Final data collection date for primary outcome measure) |
Two hundred and fifty samples from unrelated patients, from which 150 were provided by the national reference center of rare disease in Montpellier and 100 recruited in the 9 participating centers over a period of two years."To identify the missing genes, we proceed in two steps. A first step in selecting families negative for the 8 major genes genes, by systematic sequencing of exons most frequently involved. A second step in finding new loci / genes by locus exclusion using microsatellite markers and SNP genotyping.
Eligibility| Ages Eligible for Study: | 5 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- retinitis pigmentosa diagnosed
- Autosomal dominant transmission diagnosed
Exclusion Criteria:
-
Contacts and Locations| Contact: christian HAMEL, Pr Ph.D | +33 4 99 63 60 10 | Christian.hamel@inserm.fr |
| France | |
| CHRU Montpellier | Recruiting |
| Montpellier, France | |
| Contact: CHRISTIAN HAMEL, Pr Ph.D +33 4 99 63 60 10 Christian.hamel@inserm.fr | |
| Principal Investigator: | christian HAMEL, Pr Ph.D | Institut National de la Santé Et de la Recherche Médicale, France |
| Study Chair: | José-Alain SAHEL, Pr | § Centre hospitalier national d'ophtalmologie des XV-XX, Paris,FRANCE |
| Study Chair: | Jean Louis DUFIER, Pr | Hopital Necker enfants-malades,Paris,FRANCE |
| Study Chair: | Hélène DOLLFUS, Pr | CHU de STRASBOURG, FRANCE |
| Study Chair: | sylvie ODENT, Pr | CHU de RENNES Unité INSERM 598,Paris,FRANCE |
| Study Chair: | Sabine DEFOORT- DHELEMMES, Ph.D | CHRU de LILLE,FRANCE |
| Study Chair: | Michel WEBER, Pr | CHU de NANTES,FRANCE |
| Study Chair: | Xavier ZANLONGH, Ph.D | CLINIQUE SOURDILLE, NANTES,France |
More Information
Publications:
| Responsible Party: | Christian HAMEL, Pr Ph.D, INSERM |
| ClinicalTrials.gov Identifier: | NCT01235624 History of Changes |
| Other Study ID Numbers: | UF 8300, 2008-A01238-47 |
| Study First Received: | November 4, 2010 |
| Last Updated: | November 4, 2010 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by University Hospital, Montpellier:
|
Autosomal dominant retinitis pigmentosa Rare disease Genetics |
Additional relevant MeSH terms:
|
Retinitis Retinitis Pigmentosa Retinal Diseases Eye Diseases |
Eye Diseases, Hereditary Retinal Dystrophies Retinal Degeneration Genetic Diseases, Inborn |
ClinicalTrials.gov processed this record on May 16, 2013